Search Results - "Mei, Jiazhuan"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Hsa_circ_0079662 induces the resistance mechanism of the chemotherapy drug oxaliplatin through the TNF‐α pathway in human colon cancer by Lai, Mingfen, Liu, Guiju, Li, Ruijun, Bai, Hua, Zhao, Jizhi, Xiao, Peng, Mei, Jiazhuan

    Published in Journal of cellular and molecular medicine (01-05-2020)
    “…The aim of the study was to research the biological functions of circRNA (hsa_circ_0079662) and its underlying mechanism in colorectal cancer. Drug‐resistant…”
    Get full text
    Journal Article
  2. 2

    LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis by Mei, Jiazhan, Liu, Guiju, Li, Ruijun, Xiao, Peng, Yang, Dan, Bai, Hua, Hao, Yibin

    Published in Bioscience reports (01-12-2021)
    “…Cisplatin (DDP) resistance is a huge obstacle to gastric cancer (GC) treatment. Long non-coding RNAs (lncRNAs) have been manifested to exert pivotal functions…”
    Get full text
    Journal Article
  3. 3

    Circ-NUP98 Promotes Lung Adenocarcinoma Development Through Regulating CBX1 by miR-188-3p by Mei, Jie, Zuo, Jing, Mei, Jiazhuan, Liu, Guiju, Xiao, Peng

    Published in Biochemical genetics (01-10-2024)
    “…Lung cancer has a high morbidity and mortality among malignant tumors, and lung adenocarcinoma (LUAD) is the main type of lung cancer. In recent years,…”
    Get full text
    Journal Article
  4. 4

    OIP5‑AS1 modulates epigenetic regulator HDAC7 to enhance non‑small cell lung cancer metastasis via miR‑140‑5p by Mei, Jiazhuan, Liu, Guuu, Wang, Wenhui, Xiao, Peng, Yang, Dan, Bai, Hua, Li, Ruuun

    Published in Oncology letters (01-10-2020)
    “…Long non-coding RNAs have been reported to be involved in non-small cell lung cancer (NSCLC) progression. However, whether Opa-interacting protein 5 antisense…”
    Get full text
    Journal Article
  5. 5

    Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy by Wu, Hong, Yao, Li, Mei, Jiazhuan, Li, Feng

    “…In this study, we report an active targeting liposomal formulation directed by a novel peptide (T7) that specifically binds to the transferrin receptor (TfR)…”
    Get full text
    Journal Article
  6. 6

    Predictive Factors for Customizing Chemotherapy on Advanced Lung Adenocarcinoma by Xu, Hong, Mei, Jiazhuan

    Published in Zhongliu fangzhi yanjiu (01-01-2016)
    “…We all know that molecular targeted therapy could significantly improve the survival and quality of life of the patients with advanced lung adenocarcinoma…”
    Get full text
    Journal Article
  7. 7

    Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy by Wu, Hong, Yao, Li, Mei, Jiazhuan, Li, Feng

    “…In this study, we report an active targeting liposomal formulation directed by a novel peptide (T7) that specifically binds to the transferrin receptor (TfR)…”
    Get full text
    Journal Article
  8. 8

    Killing Effect of Paclitaxel and Cisplatin on EGFR-wild and Mutant Lung Adenocarcinoma Cells and Related Molecular Mechanism by Xu, Hong, Mei, Jiazhuan, Li, Ruijun, Zhao, Jizhi

    Published in Zhongliu fangzhi yanjiu (01-01-2016)
    “…Objective To investigate the relationship between the expression of chemotherapy-related genes and epidermal growth factor receptor (EGFR) mutation status, and…”
    Get full text
    Journal Article
  9. 9

    Expression of major histocompatibility complex class Ⅰ chain-related protein A and B in operable lung adenocarcinoma and its clinical significance by Zhao, J Z, Mei, J Z, Song, W, Liu, G J, Feng, R T

    Published in Zhong hua yi xue za zhi (12-07-2016)
    “…To explore the expression of major histocompatibility complex classⅠchain-related protein A and B (MICA/B) in operable lung adenocarcinoma and its clinical…”
    Get more information
    Journal Article